Brief: Venus Medtech Hangzhou Posts FY Capex Of RMB41.6 Mln
28/03/2025 16:17
March 28 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK: FY CAPEX RMB 41.6 MILLION FY REVENUE RMB 470.8 MILLION FY GROSS MARGIN 78.1% FY LOSS ATTRIBUTABLE RMB714.3 MILLION Further company coverage: 2500.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market